跳至主要内容
临床试验/JPRN-jRCT2031220579
JPRN-jRCT2031220579已完成1 期

A Phase 1 Study of Apraglutide (Single Dose Study)

Kozaki Tomohito0 个研究点目标入组 36 人开始时间: 2023年1月22日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 < 45age old(—)
性别
All

入选标准

  • The subjects will be individuals who meet all of the following criteria.
  • [1] Healthy Japanese men and women
  • [2] Individuals >=18 to <45 years of age at the time of informed consent
  • [3] Individuals who fully understand the details of the study and who are capable of providing written informed consent

排除标准

  • Individuals meeting any of the following criteria will be excluded from the study.
  • [1] Past history of disease in organsystems considered unsuitable for this study
  • [2] Past history of disease or surgery that could affect pharmacokinetic or pharmacodynamic evaluation
  • [3] Other protocol defined exclusion criteria could apply

研究者

发起方
Kozaki Tomohito

相似试验